Antisense knockdown of the rat α7 nicotinic acetylcholine receptor produces spatial memory impairment

被引:54
作者
Curzon, Peter [1 ]
Anderson, David J. [1 ]
Nikkel, Arthur L. [1 ]
Fox, Gerard B. [1 ]
Gopalakrishnan, Murali [1 ]
Decker, Michael W. [1 ]
Bitner, Robert S. [1 ]
机构
[1] Abbott Labs, GPRD, Neurosci Res, Abbott Pk, IL 60064 USA
关键词
nicotinic alpha 7; hippocampus; cortex; spatial memory; water maze;
D O I
10.1016/j.neulet.2006.09.061
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Selective and brain penetrating pharmacological antagonists for use in clarifying a role of alpha 7 nicotinic acetylcholine receptors (nAChR) in behavioral paradigms are presently unavailable. Studies in alpha 7 knock-out mice (KO) have not revealed convincing changes in behavioral phenotype, in particular measures of cognition that include contextual fear conditioning and spatial memory, which may be due to compensatory developmental changes. Therefore, an antisense oligonucleotide (aON) targeted toward the 3'- and 5'-UTR coding regions of the rat alpha 7 nicotinic acetylcholine receptor was used. Following central injection of aON into the lateral ventricle of Long Evans rats for 6 days, treated rats exhibited a significant 42% and 25% decrease in alpha 7 nAChR densities in hippocampus and cortex, respectively, as measured by [H-3]-methyllycaconitine (MLA) binding. There was no change in alpha 4 beta 2 densities measured by [H-3]-cytisine binding. Acquisition of Morris Water Maze (MWM) performance, a measure of spatial memory, was impaired in aON-treated rats. In addition, a reduction in target platform crossings during a subsequent probe-trial was observed. These data demonstrate the ability of this aON to reduce hippocampal and cortical alpha 7 nicotinic receptor densities associated with impaired MWM performance and support the specific involvement of the alpha 7 nAChR in spatial learning and memory, a phenotype not affected in alpha 7 KO mice. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 22 条
[1]   In vitro and in vivo effects of an α3 neuronal nicotinic acetylcholine receptor antisense oligonucleotide [J].
Adams, MR ;
Nikkel, AL ;
Donnelly-Roberts, DL ;
Watt, AT ;
Johnston, JF ;
Cowsert, LM ;
Butler, M ;
Kroeger, PE ;
Frost, L ;
Curzon, P ;
Decker, MW ;
Bitner, RS .
MOLECULAR BRAIN RESEARCH, 2004, 129 (1-2) :67-79
[2]   Ventral hippocampal α7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze [J].
Bettany, JH ;
Levin, ED .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (04) :467-474
[3]   Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat [J].
Bitner, RS ;
Nikkel, AL ;
Curzon, P ;
Donnelly-Roberts, DL ;
Puttfarcken, PS ;
Namovic, M ;
Jacobs, IC ;
Meyer, MD ;
Decker, MW .
BRAIN RESEARCH, 2000, 871 (01) :66-74
[4]   Applications of the Morris water maze in the study of learning and memory [J].
D'Hooge, R ;
De Deyn, PP .
BRAIN RESEARCH REVIEWS, 2001, 36 (01) :60-90
[5]   Characterisation of the binding of [3H]methyllycaconitine:: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors [J].
Davies, ARL ;
Hardick, DJ ;
Blagbrough, IS ;
Potter, BVL ;
Wolstenholme, AJ ;
Wonnacott, S .
NEUROPHARMACOLOGY, 1999, 38 (05) :679-690
[6]   Neuronal nicotinic receptors: from structure to pathology [J].
Gotti, C ;
Clementi, F .
PROGRESS IN NEUROBIOLOGY, 2004, 74 (06) :363-396
[7]   Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers [J].
Kitagawa, H ;
Takenouchi, T ;
Azuma, R ;
Wesnes, KA ;
Kramer, WG ;
Clody, DE ;
Burnett, AL .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (03) :542-551
[8]  
KOLB SR, 1983, BEHAV NEUROSCI, V97, P13
[9]   Hippocampal α7 and α4β2 nicotinic receptors and working memory [J].
Levin, ED ;
Bradley, A ;
Addy, N ;
Sigurani, N .
NEUROSCIENCE, 2002, 109 (04) :757-765
[10]   Nicotinic receptor subtypes and cognitive function [J].
Levin, ED .
JOURNAL OF NEUROBIOLOGY, 2002, 53 (04) :633-640